Work to develop peptidomimetics against breast cancer highlighted

The ongoing work in the laboratory to develop the peptidomimetics in breast cancer was selected for a podium presentation at the San Antonio Breast Cancer Symposium. This work details the development of a novel agent in estrogen-receptor-positive breast cancer developed in collaboration with Dr. Ratna Vadlamudi at UT San Antonio Health Science Center and Dr. Jung Mo Ahn at UT Dallas. The work was selected for highlights by eCancer TV, Novel estrogen receptor-targeting agent represents ‘quantum leap’